logo-loader

Ananda Develops U.S. presence as lead drug advances to Phase 1 clinical study

Ananda Pharma CEO Melissa Sturgess joined Steve Darling from Proactive to announce the company’s shares have begun trading on the OTCQB market in the United States, using the ticker ANANF. This a strategic move that expands Ananda’s visibility and access to U.S. investors. The UK-based...

on 14/4/25

Join Proactive

Get ahead of the curve